NCT06405971View on ClinicalTrials.gov

Metformin in Patients with Unruptured Vertebrobasilar Dissecting Aneurysms (METTLE)

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

June 1, 2025

Conditions

Dissecting Aneurysm of Cerebral Artery

Interventions

DRUG

Metformin

Patients in the drug group took one tablet of metformin hydrochloride enteric capsule orally each day after breakfast and dinner, and the dose of each tablet was 250mg.

Trial Locations (1)

100010

RECRUITING

Beijing Tiantan Hospital, Beijing

All Listed Sponsors

lead

Ming Lv

OTHER